Breakthrough Hope : OCREVUS® - A New Treatment Option for Multiple Sclerosis Patients
Roche (Malaysia) Sdn. Bhd. recently announced the availability of OCREVUS® in Malaysia, a twice-yearly convenient dosing option for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).